← Back to Search

High Intensity Interval Training (HIIT) for Trauma and Stressor Related Disorders

N/A
Waitlist Available
Led By Patrick J O'Connor, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 7

Summary

This trial tests if intense exercise can help women with PTSD sleep better by improving heart health and reducing anxiety. Women will do short, intense workouts regularly over a period of time.

Eligible Conditions
  • Trauma and Stressor Related Disorders
  • Traumatic Stress Disorders
  • Post-Traumatic Stress Disorder
  • Mental Illness
  • Exercise

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to week 7 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Heart Rate Variability
Pittsburg Sleep Quality Index (PSQI)
State Trait Anxiety Inventory (STAI-Y2)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention
High-intensity interval training will be performed three times a week for a total of six weeks.
Group II: Waitlist ControlPlacebo Group1 Intervention
Waitlist participants were tested on the outcomes at the same time points as the treatment group (i.e., HIIT). Following completion of the waitlist treatment, participants will be eligible to receive a supervised exercise program (no data will be collected). The waitlist participants formed a no-treatment control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High Intensity Interval Training (HIIT)
2022
N/A
~240

Find a Location

Who is running the clinical trial?

University of GeorgiaLead Sponsor
103 Previous Clinical Trials
45,017 Total Patients Enrolled
Patrick J O'Connor, PhDPrincipal InvestigatorUniversity of Georgia
3 Previous Clinical Trials
162 Total Patients Enrolled
~11 spots leftby Dec 2025